Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.710
+0.030 (1.12%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 226 employees as of December 31, 2025. The number of employees increased by 13 or 6.10% compared to the previous year.
Employees
226
Change (1Y)
13
Growth (1Y)
6.10%
Revenue / Employee
$356,721
Profits / Employee
$83,827
Market Cap
218.35M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 226 | 13 | 6.10% | 226 | 0 |
| Dec 31, 2024 | 213 | 5 | 2.40% | 213 | 0 |
| Dec 31, 2023 | 208 | 11 | 5.58% | 208 | 0 |
| Dec 31, 2022 | 197 | -9 | -4.37% | 193 | 4 |
| Dec 31, 2021 | 206 | -1 | -0.48% | 202 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| ProQR Therapeutics | 187 |
| Entrada Therapeutics | 152 |
| Alector | 103 |
| Keros Therapeutics | 92 |
| Lineage Cell Therapeutics | 77 |
| Cartesian Therapeutics | 75 |
| Compugen | 75 |
PLX News
- 17 days ago - Protalix BioTherapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 25 days ago - Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences - PRNewsWire
- 7 weeks ago - Protalix BioTherapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 7 weeks ago - Protalix BioTherapeutics Earnings release: Q2 2026 - Filings
- 7 weeks ago - Protalix BioTherapeutics Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Protalix BioTherapeutics Slides: Corporate presentation - Filings
- 7 weeks ago - Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results - PRNewsWire
- 1 month ago - Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026 - PRNewsWire